The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global vital signs monitoring devices market size reached US$ 5.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2027, exhibiting a growth rate (CAGR) of 6.8% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Vital signs monitoring devices refer to various medical equipment used for monitoring a patient's vital signs. This includes blood pressure monitoring devices, pulse oximeters and temperature monitoring devices that are used for observing various vital signs, such as blood pressure, body temperature, pulse rate and respiratory rate. These devices are portable, small-sized, reliable and can be set up in a medical setting, residential complexes and at the site of a medical emergency. They can also be used for monitoring activity and fitness levels for self-health tracking and early diagnosis of medical ailments.
The increasing prevalence of chronic and lifestyle-associated medical ailments across the globe is one of the key factors driving the growth of the market. Furthermore, growing geriatric population and increasing awareness regarding home monitoring devices are also providing a boost to the market growth. As at-home vital signs monitoring devices are cost-effective, easy-to-use and can measure various physiological parameters of the body using multi-parameter patient monitors, it is contributing to their rising demand. Apart from this, the onset of COVID-19 (coronavirus disease) has led to a significant increase in the demand of these devices to determine the patient’s health status, provide them with appropriate care and predict recovery. Additionally, various technological advancements, such as the integration of health monitoring devices with bluetooth, sensors and micro-electric technologies, are also creating a positive outlook for the market. Other factors, including improvements in the healthcare infrastructure and the increasing adoption of wearable healthcare devices, are expected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global vital signs monitoring devices market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type and end-user.
Breakup by Product Type:
Breakup by End-User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being A&D Company Ltd., Contec Medical Systems Co. Ltd., GE Healthcare, Koninklijke Philips N.V., Masimo, Medtronic, Nihon Kohden Corporation, Nonin Medical Inc., Omron Healthcare Inc., Smiths Group Plc, etc.
|Base Year of the Analysis||2021|
|Segment Coverage||Product Type, End-User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||A&D Company Ltd., Contec Medical Systems Co. Ltd., GE Healthcare, Koninklijke Philips N.V., Masimo, Medtronic, Nihon Kohden Corporation, Nonin Medical Inc., Omron Healthcare Inc. and Smiths Group Plc|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
The global vital signs monitoring devices market was valued at US$ 5.0 Billion in 2021.
We expect the global vital signs monitoring devices market to exhibit a CAGR of 6.8% during 2022-2027.
The high prevalence of several chronic and lifestyle-associated medical ailments, along with the rising need for their early diagnosis and accurate treatment, is primarily driving the global vital signs monitoring devices market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing demand for home vital signs monitoring devices to determine the coronavirus-infected patient’s health status, provide appropriate care, and predict recovery, owing to the temporary shortage of beds across numerous hospitals.
Based on the product type, the global vital signs monitoring devices market has been segmented into BP monitoring devices, pulse-oximeters, temperature monitoring devices, and others. Among these, BP monitoring devices currently hold the majority of the total market share.
Based on the end-user, the global vital signs monitoring devices market can be divided into hospitals and clinics, Ambulatory Surgery Centers (ASCs), home care, and others. Currently, hospitals and clinics exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global vital signs monitoring devices market include A&D Company Ltd., Contec Medical Systems Co. Ltd., GE Healthcare, Koninklijke Philips N.V., Masimo, Medtronic, Nihon Kohden Corporation, Nonin Medical Inc., Omron Healthcare Inc., Smiths Group Plc, etc.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at